The Southern Medical Journal (SMJ) is the official, peer-reviewed journal of the Southern Medical Association. It has a multidisciplinary and inter-professional focus that covers a broad range of topics relevant to physicians and other healthcare specialists.

SMJ // Article

Original Article

Prostate Cancer Screening Shared Decision Making and Prostate-Specific Antigen Testing in Black and Non-Black Men in Primary Care in South Carolina

Authors: Nicholas Shungu, MD, MPH, Jaylynne Le, MD, Nekia E. Robinson, MS, MPH, Vanessa Diaz, MD, MSCR

Abstract

Objective: Black men experience disproportionate prostate cancer mortality compared with men of other races. As of 2018, major guidelines concur that all men make informed decisions about whether to be screened for prostate cancer after a discussion with their clinician. The objectives of this study were to determine the frequency at which clinicians document prostate cancer screening shared decision-making (SDM) conversations, to examine whether SDM documentation rates differ by race and other sociodemographic factors, and to evaluate whether SDM affects rates of prostate cancer screening.

Methods: We conducted retrospective chart reviews of a random sample of men (N = 600) aged 45 to 69 years seen within an academic family medicine practice in South Carolina in 2019-2020. We used ?2 analyses to compare documentation of a prostate cancer SDM conversation and prostate-specific antigen (PSA) testing by race, age, family history of cancer, family history of prostate cancer, colon cancer screening adherence, and insurance. Logistic regressions assessed the effect of SDM, race, age, and insurance status on the completion of screening PSAs.

Results: SDM conversations were documented for 7.3% of Black men and 5.3% of non-Black men (P = 0.37). Screening PSAs were ordered in 39.7% of Black men and 36.0% of non-Black men (P = 0.41). SDM conversations were positively associated with prostate cancer screening in all men (71.8% vs 35.6%, P < 0.01) and Black men specifically (85.0% vs 35.7%, P < 0.01).

Conclusions: Our results indicate very low rates of prostate cancer SDM in Black and non-Black men. Men with documented SDM conversations were significantly more likely to receive prostate cancer screening. Study results suggest the need for increased SDM in all patients and the need for improved clinician documentation of SDM conversations to evaluate whether men receive the standard of care regarding prostate cancer screening.
Posted in: Prostate Disorders4

This content is limited to qualifying members.

Existing members, please login first

If you have an existing account please login now to access this article or view purchase options.

Purchase only this article ($25)

Create a free account, then purchase this article to download or access it online for 24 hours.

Purchase an SMJ online subscription ($75)

Create a free account, then purchase a subscription to get complete access to all articles for a full year.

Purchase a membership plan (fees vary)

Premium members can access all articles plus recieve many more benefits. View all membership plans and benefit packages.

References

1. Giaquinto AN, Miller KD, Tossas KY, et al. Cancer statistics for African American/Black people 2022. CA Cancer J Clin 2002;72:202-229.  
2. Barber L, Gerke T, Markt SC, et al. Family History of Breast or Prostate Cancer and Prostate Cancer Risk. Clin Cancer Res 2018;24:5910-5917.
 
3. Rawla P. Epidemiology of Prostate Cancer. World Journal of Oncology 2019; 10:63-89.
 
4. Hugosson J, Roobol MJ, Månsson M, et al. A 16-yr Follow-up of the European Randomized Study of Screening for Prostate Cancer. Eur Urol 2019;76:43-51.
 
5. US Preventive Services Task Force. Screening for prostate cancer: US Preventive Services Task Force Recommendation Statement. JAMA 2018;319:1901-1913.
 
6. Nyame YA, Gulati R, Heijnsdijk EAM, et al. The Impact of Intensifying Prostate Cancer Screening in Black Men: A Model-Based Analysis. J Natl Cancer Inst 2021;113:1336-1342.
 
7. Kensler KH, Pernar CH, Mahal BA, et al. Racial and Ethnic Variation in PSA Testing and Prostate Cancer Incidence Following the 2012 USPSTF Recommendation. J Natl Cancer Inst 2021;113:719-726.
 
8. Desai MM, Cacciamani GE, Gill K, et al. Trends in Incidence of Metastatic Prostate Cancer in the US. JAMA Network Open 2022;5:e222246.
 
9. Wei JT, Barocas D, Carlsson S, et al. Early detection of prostate cancer: AUA/SUO guideline part I: prostate cancer screening. J Urol 2023;210:45-53.
 
10. American Cancer Society. Recommendations for Prostate Cancer Early Detection. https://www.cancer.org/cancer/types/prostate-cancer/detection-diagnosis-staging/acs-recommendations.html. Published November 22, 2023. Accessed July 31, 2025.
 
11. Jiang C, Fedewa SA, Wen Y, et al. Shared decision making and prostate-specific antigen based prostate cancer screening following the 2018 update of USPSTF screening guideline. Prostate Cancer Prostatic Dis 2021;24:77-80.
 
12. Leyva B, Persoskie A, Ottenbacher A, et al. Do Men Receive Information Required for Shared Decision Making About PSA Testing? Results from a National Survey. J Cancer Educ 2016;31:693-701.
 
13. Shungu N, Sterba KR. Barriers and Facilitators to Informed Decision-Making About Prostate Cancer Screening Among Black Men. J Am Board Fam Med 2021;34:925-936.
 
14. Fedewa SA, Gansler T, Smith R, et al. Recent Patterns in Shared Decision Making for Prostate-Specific Antigen Testing in the United States. Ann Fam Med 2018;16:139-144.
 
15. Han PK, Kobrin S, Breen N, et al. National evidence on the use of shared decision making in prostate-specific antigen screening. Ann Fam Med 2013;11:306-314.
 
16. Landrey AR, Matlock DD, Andrews L, et al. Shared decision making in prostate-specific antigen testing: the effect of a mailed patient flyer prior to an annual exam. J Prim Care Community Health 2013;4:67-74.
 
17. Frego N, Beatrici E, Labban M, et al. Racial Disparities in Prostate Cancer Screening: The Role of Shared Decision Making. Am J Prev Med 2024;66:27-36.
 
18. Stevens ER, Thomas J, Martinez-Lopez N, et al. Limited Evidence of Shared Decision Making for Prostate Cancer Screening in Audio-Recorded Primary Care Visits Among Black Men and their Healthcare Providers. J Immigr Minor Health 2024;26:866-877.
 
19. Carlsson SV, Preston M, Vickers A, et al. Provider Perceptions of an Electronic Health Record Prostate Cancer Screening Tool. Appl Clin Inform 2024;15:282-294.
 
20. Golijanin B, Bhatt V, Homer A, et al. Shared decision-making” for prostate cancer screening: is it a marker of quality preventative healthcare. Cancer Epidemiol 2024;88:102492.
 
21. McCormick ME, Haile ZT. The Impact of Receipt of Information on Prostate-Specific Antigen Testing on Screening with the Prostate-Specific Antigen Test. J Cancer Educ 2023;38:1313-1321.
 
22. Li J, Zhao G, Hall IJ. Pre-screening Discussions and Prostate-Specific Antigen Testing for Prostate Cancer Screening. Am J Prev Med 2015;49:259-263.
 
23. Martí-Gonzá NA, Neuner-Jehle S, Plate A, et al. The effects of shared decision-making compared to usual care for prostate cancer screening decisions: a systematic review and meta-analysis. BMC Cancer 2018;18:1015.
 
24. Weinrich SP. Prostate cancer screening in high-risk men: African American Hereditary Prostate Cancer Study Network. Cancer 2006;106:796-803.
 
25. Mahal AR, Mahal BA, Nguyen PL, et al. Prostate cancer outcomes for men aged younger than 65 years with Medicaid versus private insurance. Cancer 2018;124:752-759.
 
26. Bhojani N, Miller LE, Zorn K. Prevalence and determinants of shared decision-making for PSA testing in the United States. Prostate Cancer Prostatic Dis 2025;28:400-404.